For the Inventor, By the Inventor

Enter assignee name

Cleveland, OH, United States of America

Gliatech, Inc.

USPTO Granted Patents = 17

Trademarks = 1

Forward Citations = 479

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Adrian Harel (8 out of 9 patents)

Dikla Roufa (8 out of 9 patents)

George T Coker, Iii (7 out of 8 patents)

4. Clark E Tedford (7 out of 7 patents)

5. Robert C Frederickson (7 out of 7 patents)

6. James G Phillips (6 out of 13 patents)

7. Amin Mohammed Khan (5 out of 9 patents)

8. Syed M Ali (3 out of 6 patents)

9. Stephen L Yates (2 out of 4 patents)

10. Kurt R Brunden (2 out of 4 patents)

11. Nishith C Chaturvedi (2 out of 8 patents)

12. Graham J Durant (1 out of 29 patents)

13. Robert C A Frederickson (1 out of 2 patents)

14. Loyd H Burgess (1 out of 1 patent)

15. Michael J Gallagher (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 6448282 - 1H-4(5)-substituted imidazole derivatives (2002-09-10),

2. 6417173 - Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers (2002-07-09),

3. 6416975 - Human glycine transporter type 2 (2002-07-09),

4. 6333034 - Process for inhibiting complement activation via the alternative pathway (2001-12-25),

5. 6166060 - 1H-4(5)-substituted imidazole derivatives (2000-12-26),

6. 6127348 - Methods and compositions based on inhibition of cell invasion and (2000-10-03),

7. 6083930 - Methods and compositions based on inhibition of cell invasion and (2000-07-04),

8. 6072057 - 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 (2000-06-06),

9. 6020326 - Method for inhibition of bone growth by anionic polymers (2000-02-01),

10. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),

11. 5994325 - Methods and compositions based on inhibition of cell invasion and (1999-11-30),

12. 5990317 - 2-(1H-4(5)-imidazoyl) cyclopropyl compounds (1999-11-23),

13. 5705178 - Methods and compositions based on inhibition of cell invasion and (1998-01-06),

14. 5705177 - Methods and compositions based on inhibition of cell invasion and (1998-01-06),

15. 5652258 - 2-(4-imidazoyl) cyclopropyl derivatives (1997-07-29),

Company Overview

Gliatech, Inc. is a biotechnology company based in Cleveland, Ohio, specializing in the development of innovative therapeutic solutions for neurological disorders. The organization focuses on harnessing advanced biomaterials and regenerative medicine technologies to create products that promote nerve repair and regeneration. Gliatech's research emphasizes the intersection of cellular biology and material science, aiming to address unmet medical needs in the field of neurology and enhance patient outcomes through cutting-edge treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#116 in Cleveland, OH

#807 in Ohio

#18,894 in US

#35,918 in the World

Cleveland, OH, United States of America

Gliatech, Inc.

Forward Citations = 479

17 inventors:

Adrian Harel (8 out of 9 patents)

Dikla Roufa (8 out of 9 patents)

George T Coker, Iii (7 out of 8 patents)

4. Clark E Tedford (7 out of 7 patents)

5. Robert C Frederickson (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gliatech, Inc.. Retrieved from https://idiyas.com/company/gliatech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…